Andere talen Biogen Inc.

Aandelen

BIIB

US09062X1037

Farmaceutische producten

Geschatte realtime Cboe BZX Andere beurzen 18:25:22 11-06-2026			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
198,70 ^USD	+2,30%		+0,98%	+12,73%

08/06	BIOGEN INC. : Needham & Co. zet aandeel op kooplijst	ZM
04/06	Biogen ontvangt FDA Breakthrough Therapy Designation voor Salanersen bij spinale musculaire atrofie	CI

Andere talen

05/06	UCB - EULAR 2026, Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus
05/06	Biogen's Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy
04/06	Biogen Receives FDA Breakthrough Therapy Designation for Salanersen for Spinal Muscular Atrophy
04/06	Biogen Gets FDA Breakthrough Designation for Spinraza Successor Salanersen
04/06	Biogen Says FDA Granted Granted Breakthrough Therapy Designation for Spinal Muscular Atrophy Drug
04/06	Des avancées dans l'AMS et le LES pour Biogen
04/06	UCB and Biogen Inc. Demonstrate Clinical Profile of Dapirolizumab Pegol in Systemic Lupus Erythematosus At EULAR 2026
04/06	Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy
04/06	Biogen Says New Data Show Dapirolizumab Pegol's Potential to Maintain Disease Control in Systemic Lupus Erythematosus
04/06	EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus
03/06	Bourse : 135 USD pour une action SpaceX, gros contrat pour Eiffage
03/06	L'Europe veut revenir dans la course technologique
01/06	Wall Street comienza junio en tensión
01/06	Wall Street startet nervös in den Juni
01/06	Wall Street Starts June on Edge
01/06	Biogen, UCB Say Lupus Drug Candidate Meets Primary Endpoint in Phase 3 Trial
01/06	Bourse : Softbank choisit Schneider, de l'intérêt pour easyJet, Nvidia attaque AMD et Intel
01/06	Morning Meeting: Primavera explosiva para la renta variable
01/06	Morning Meeting: Ein explosiver Frühling für Aktien
01/06	Un printemps explosif en bourse
01/06	UCB and Biogen announce positive DZP phase 3 study results
28/05	Biogen : Announces Webcast of Annual Meeting of Stockholders
27/05	Italy probes Biogen for allegedly hindering sales of rival's MS drug
27/05	Italian Competition Watchdog Launches Probe into Biogen Over Alleged Market Abuse
27/05	Biogen Faces Italian Antitrust Probe Over Multiple Sclerosis Drug Competition